β-Lactamase-non-producing ampicillin-resistant Haemophilus influenzae is acquiring multidrug resistance.

[1]  E. Tanaka,et al.  Emergence of Haemophilus influenzae with low susceptibility to quinolones and persistence in tosufloxacin treatment. , 2019, Journal of global antimicrobial resistance.

[2]  Y. Adachi,et al.  Genotypic characterization of Haemophilus influenzae isolates from paediatric patients in Japan , 2018, Journal of medical microbiology.

[3]  H. Sakata,et al.  Invasive Haemophilus influenzae infections in children in Kamikawa subprefecture, Hokkaido, Japan, 2006-2015: The effectiveness of H. influenzae type b vaccine. , 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[4]  T. Hoshino,et al.  Emergence of quinolone-resistant strains in Streptococcus pneumoniae isolated from paediatric patients since the approval of oral fluoroquinolones in Japan. , 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[5]  T. Wajima,et al.  Rise in Haemophilus influenzae With Reduced Quinolone Susceptibility and Development of a Simple Screening Method , 2017, The Pediatric infectious disease journal.

[6]  E. Bancroft,et al.  Epidemiology of Invasive Haemophilus influenzae Disease, Europe, 2007–2014 , 2017, Emerging infectious diseases.

[7]  R. Hasan,et al.  Fluoroquinolone consumption and -resistance trends in Mycobacterium tuberculosis and other respiratory pathogens: Ecological antibiotic pressure and consequences in Pakistan, 2009–2015 , 2016, International journal of mycobacteriology.

[8]  T. Wajima,et al.  Prevalence of macrolide-non-susceptible isolates among β-lactamase-negative ampicillin-resistant Haemophilus influenzae in a tertiary care hospital in Japan. , 2016, Journal of global antimicrobial resistance.

[9]  H. Hanaki,et al.  Nationwide survey of the development of drug resistance in the pediatric field in 2000-2001, 2004, 2007, 2010, and 2012: evaluation of the changes in drug sensitivity of Haemophilus influenzae and patients' background factors. , 2015, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[10]  Dong‐Gun Lee,et al.  Genetic diversity of the ftsI gene in β-lactamase-nonproducing ampicillin-resistant and β-lactamase-producing amoxicillin-/clavulanic acid-resistant nasopharyngeal Haemophilus influenzae strains isolated from children in South Korea. , 2013, Microbial drug resistance.

[11]  K. Kimura,et al.  High frequency of fluoroquinolone- and macrolide-resistant streptococci among clinically isolated group B streptococci with reduced penicillin susceptibility. , 2013, The Journal of antimicrobial chemotherapy.

[12]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[13]  A. Hamidi,et al.  Development and technology transfer of Haemophilus influenzae type b conjugate vaccines for developing countries. , 2012, Vaccine.

[14]  I. Anthonisen,et al.  Mutant ftsI genes in the emergence of penicillin-binding protein-mediated beta-lactam resistance in Haemophilus influenzae in Norway. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[15]  H. Sakata,et al.  Nationwide survey of the development of drug-resistance in the pediatric field: drug sensitivity of Haemophilus influenzae in Japan , 2009, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[16]  S. Yokota,et al.  Emergence of Fluoroquinolone-Resistant Haemophilus influenzae Strains among Elderly Patients but Not among Children , 2007, Journal of Clinical Microbiology.

[17]  J. Campos,et al.  Fluoroquinolone Resistance in Haemophilus influenzae Is Associated with Hypermutability , 2007, Antimicrobial Agents and Chemotherapy.

[18]  K. Ubukata,et al.  Molecular Evolution of β-Lactam-Resistant Haemophilus influenzae: 9-Year Surveillance of Penicillin-Binding Protein 3 Mutations in Isolates from Japan , 2006, Antimicrobial Agents and Chemotherapy.

[19]  D. Rao,et al.  DNA mismatch correction in Haemophilus influenzae: characterization of MutL, MutH and their interaction. , 2004, DNA repair.

[20]  E. Moxon,et al.  Mutations in Haemophilus influenzae Mismatch Repair Genes Increase Mutation Rates of Dinucleotide Repeat Tracts but Not Dinucleotide Repeat-Driven Pilin Phase Variation Rates , 2004, Journal of bacteriology.

[21]  T. Popović,et al.  Characterization of Encapsulated and Noncapsulated Haemophilus influenzae and Determination of Phylogenetic Relationships by Multilocus Sequence Typing , 2003, Journal of Clinical Microbiology.

[22]  K. Yamamoto,et al.  Association of Amino Acid Substitutions in Penicillin-Binding Protein 3 with β-Lactam Resistance in β-Lactamase-Negative Ampicillin-Resistant Haemophilus influenzae , 2001, Antimicrobial Agents and Chemotherapy.

[23]  R. Singleton,et al.  Invasive Haemophilus influenzae disease in Alaskan residents aged 10 years and older before and after infant vaccination programs. , 2000, JAMA.

[24]  D. Fish,et al.  The Clinical Pharmacokinetics of Levofloxacin , 1997, Clinical pharmacokinetics.

[25]  D. Maskell,et al.  PCR for capsular typing of Haemophilus influenzae , 1994, Journal of clinical microbiology.

[26]  H. Sadoff,et al.  Mechanisms of Ampicillin Resistance in Haemophilus influenzae Type B , 1976, Antimicrobial Agents and Chemotherapy.